Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks
Notified -
Globe Newswire8-12-2025, 19:30
Impulse Dynamics® Celebrates CMS National Coverage Determination for CCM® Therapy 29-10-2025, 21:00